NCT06052072 - Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 20, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

July 1, 2028

Conditions

Group 2 Pulmonary HypertensionHeart Failure

Interventions

DEVICE

Gradient Denervation System

Pulmonary artery denervation (PADN) procedure using the Gradient Denervation System to ablate nerves within the pulmonary artery using ultrasonic ablation.

Trial Locations (8)

27708

RECRUITING

Duke University, Durham

29425

RECRUITING

Medical University of South Carolina, Charleston

53215

RECRUITING

Aurora Health, Milwaukee

53705

RECRUITING

University of Wisconsin, Madison

60611

RECRUITING

Northwestern University, Chicago

77030

RECRUITING

Baylor College of Medicine, Houston

RECRUITING

Houston Methodist, Houston

02114

RECRUITING

Massachusetts General Hospital, Boston